PRWeb The Leader Press Release Distribution

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for April 2, 2008 Subscribe to this News Feed    
 

Americas Watchdog Launches National Investigation On Vytorin & Zetia

Americas Watchdog is launching a U.S. investigation involving the effectiveness of the cholesterol medications called Vytorin and Zetia. The question becomes, were these drugs as effective as portrayed on national television advertising? According to news reports released on March 31, 2008 they were not. According to Americas Watchdog, "either drugs work as advertised, or you don't risk the health of U.S. citizens with false advertising."

(PRWEB) April 2, 2008 -- Americas Watchdog and its Corporate Whistle Blower Center have launched a national investigation into the effectiveness of the heart medications touted as cholesterol fighting drugs named Vttorin and Zetia.

Americas Watchdog is one of the leaders in investigating the heart medication called Trasylol & if it was in fact responsible for the deaths of more than 22,000 U.S. citizens. The suggestion that 22,000 US Citizens may have died from Trasylol, was portrayed on the news program 60 Minutes. Americas Watchdog now wants to know if the drugs Vytorin or Zetia actually reduced cholesterol as advertised in glitzy TV promotions. According to Americas Watchdog, "You can't have it both ways, either these drugs work or they don't. There is no middle ground."

According to a recent press conference: Merck and Schering said that not only did Zetia fail to slow the accumulation of fatty plaque in the arteries, it actually seemed to contribute to plaque formation --- although by such a small amount that the finding could have been a result of chance.

"This is as bad a result for the drug as anybody could have feared," said Dr. Nissen, a widely published researcher and senior consulting editor to the Journal of the American College of Cardiology. Millions of patients may be taking a drug that does not benefit them, raising their risk of heart attacks and exposing them to potential side effects".

If a consumer was taking Vytorin or Zetia and suffered an actual increase in cholesterol or a heart attack they should contact Americas Watchdog Immediately at 866-714-6466. Americas Watchdog is interested in discovering the following:

 
  • Did the use of Vytorin or Zetia have no affect on a users cholesterol, or did cholesterol actually get worse?
  • Was the use of Vytorin or Zetia combined with a massive heart attack?
  • Did a loved one lose a person who was taking Vytorin or Zetia to a massive heart attack?
If the answer is yes, a consumer or a loved one should contact Americas Watchdog immediately at 866-714-6466.

If a medical professional, a physician or a drug sales rep has specific information about any of these drugs they should contact Americas Watchdog immediately at 866-714-6466.

Americas Watchdog & its Corporate Whistle Blower Center are all about consumer protection and corporate responsibility. Their web site is located at http://AmericasWatchdog.com.

OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
THOMAS MARTIN
Americas Watchdog
866-714-6466
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.